Lessons From MAVERICK-HCM: The Need for Less Speed

Jane E Wilcox; Elizabeth M McNally

doi:10.1016/j.jacc.2020.04.017

Lessons From MAVERICK-HCM: The Need for Less Speed

J Am Coll Cardiol. 2020 Jun 2;75(21):2661-2663. doi: 10.1016/j.jacc.2020.04.017.

Authors

Jane E Wilcox¹, Elizabeth M McNally²

Affiliations

¹ Bluhm Cardiovascular Institute, Northwestern Medicine, Chicago, Illinois. Electronic address: [email protected].
² Bluhm Cardiovascular Institute, Northwestern Medicine, Chicago, Illinois; Center for Genetic Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois. Electronic address: https://twitter.com/emmcnally.

No abstract available

Keywords: N-terminal pro-B-type natriuretic peptide (NT-proBNP); cardiac troponin I (cTnI); clinical study; hypertrophic cardiomyopathy; mavacamten.

Publication types

Editorial
Research Support, N.I.H., Extramural
Comment

MeSH terms

Benzylamines*
Cardiomyopathy, Hypertrophic*
Humans
Uracil / analogs & derivatives

Substances

Benzylamines
MYK-461
Uracil

Grants and funding

R01 HL128075/HL/NHLBI NIH HHS/United States